AMZN
Amazon.com, Inc.
AMZN has the edge over H overall, supported by stronger valuation.
H
Hyatt Hotels Corporation
H has slightly lower modeled downside risk, despite its lower overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
H Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Weak |
H's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is weak.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over H in the historical PE scenario, which offers more potential upside but is not a forecast.
H PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $22.92 | -88% |
| Fair | 24x | $45.64 | -76% |
| Forward | 43x | $187 | — |
| Expensive | 78x | $151 | -20% |
| Current | 97x | $187 | — |
Historical ranges are pointers, not guarantees.
H's PE is in its expensive range at 97x. If earnings grow as analysts expect, today's price would be 43x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
H Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
H has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over H on earnings, with more consistent year-over-year improvement.
H Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.37 | +125% |
| Q3 2026 | $1.94 | +$2.66 |
| Q2 2026 | $0.83 | -81% |
| Q1 2026 | -$0.34 | -104% |
| Q4 2025 | -$0.55 | -104% |
| Q3 2025 | -$0.72 | -105% |
| Q2 2025 | $4.42 | -52% |
| Q1 2025 | $7.91 | +23% |
| Q4 2024 | $12.65 | +517% |
H has returned to profit: it earned $1.94 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over H on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over H on profitability, with a higher operating margin.
H Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | -2.4% |
| Q2 2026 | $1.8B | +1.2% |
| Q1 2026 | $1.7B | +1.7% |
| Q4 2025 | $1.8B | +12% |
| Q3 2025 | $1.8B | +9.6% |
| Q2 2025 | $1.8B | +6.2% |
| Q1 2025 | $1.7B | +0.2% |
| Q4 2024 | $1.6B | -3.5% |
H's revenue grew through 2023 and has held roughly level since: $1.7B last quarter, down 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.5% | +5.5 points |
| Q2 2026 | 10% | +7.8 points |
| Q1 2026 | 3.3% | +0.2 points |
| Q4 2025 | 0.5% | +3.5 points |
| Q3 2025 | -0.9% | -38 points |
| Q2 2025 | 2.1% | -25 points |
| Q1 2025 | 3% | -29 points |
| Q4 2024 | -3% | -3.5 points |
H's operating margin was 4.5% last quarter, up 5.5 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
H Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$157M | -$68M |
| Q2 2026 | $28M | +$139M |
| Q1 2026 | $77M | -37% |
| Q4 2025 | $236M | +28% |
| Q3 2025 | -$89M | -$25M |
| Q2 2025 | -$111M | -182% |
| Q1 2025 | $123M | -41% |
| Q4 2024 | $184M | -41% |
H has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over H on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
H Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -349K shares |
| 1 year | +0.9% | +835K shares |
| 3 years | -9.8% | -10.5M shares |
| 5 years | -7.3% | -7.6M shares |
| Available history | -9.4% | -9.9M shares |
H has 96M diluted shares, up 0.9% from a year ago, despite $408M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $147M |
| Q2 2026 | $12M |
| Q1 2026 | $135M |
| Q4 2025 | $114M |
| Q3 2025 | $30M |
| Q2 2025 | — |
| Q1 2025 | $149M |
| Q4 2024 | $11M |
H spent $408M buying back its own shares over the past year, up 115% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over H on leverage, with a lower net debt burden relative to earnings.
H Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.3x | High |
| Q2 2026 | 6.9x | High |
| Q1 2026 | 9.1x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 15.4x | High |
| Q2 2025 | 5.4x | High |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.5x | Healthy |
H's net debt is about 6.3 years of its operating earnings (EBITDA), down from 15 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
H Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.5 | Neutral |
| Stochastic | 79.4 | Neutral |
H's weekly RSI is 61 (neutral) and its Stochastic is 79 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over H on valuation relative to its sector.
H PE vs Consumer Cyclical Sector
| Metric | H | Sector median | Relative |
|---|---|---|---|
| PE | 97x | 18x | 436% above |
| PE % | 89 | 47 | 42 pts above |
H is trading at 97x earnings, a 436% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
H Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $171.6 | 9.1% above |
| 20 week MA | $175.2 | 6.9% above |
| 50 week MA | $169.8 | 10% above |
| 100 week MA | $155.2 | 21% above |
| 200 week MA | $143.0 | 31% above |
H is in an uptrend: it's above all five of its weekly moving averages, and 31% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over H on returns for 2026, with the stronger performance.
H Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $90.7 | $72.8 | -20% |
| 2021 | $72.8 | $93.6 | +29% |
| 2022 | $93.6 | $91.1 | -2.7% |
| 2023 | $91.1 | $130.4 | +43% |
| 2024 | $130.4 | $158.5 | +22% |
| 2025 | $158.5 | $165.7 | +4.6% |
| 2026 YTD | $165.7 | $187.2 | +13% |
H has finished higher in four of the last six years. It's up 13% so far in 2026.